Skip to main
PEPG
PEPG logo

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 60%
Buy 20%
Hold 0%
Sell 20%
Strong Sell 0%

Bulls say

PepGen Inc. is positioned favorably in the biotechnology sector, with its shares currently trading near $4, indicating potential for significant upside contingent upon positive multi-dose data. The company’s Enhanced Delivery Oligonucleotide platform has demonstrated impressive preclinical efficacy, with a 53.7% splicing correction in DM1, surpassing the performance of competitors, thereby suggesting strong therapeutic potential. Additionally, the favorable risk/benefit profile highlighted in discussions underscores the possibility of measurable improvements in muscle performance as multi-dose data progresses, instilling confidence in the company's growth prospects.

Bears say

PepGen Inc. is currently experiencing downward pressure on its stock, with a recent model update reflecting a $1 decrease in its target price to $8 per share. Despite demonstrating potential through its EDO platform, the company's discounted market capitalization appears anomalous compared to its peers, raising concerns about its competitive positioning and execution capabilities. Additionally, the inability to access capital markets could lead to significant delays or even termination of ongoing development campaigns, compounding the negative outlook for the company's financial health.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Buy. 60% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.